James Rolke - Net Worth and Insider Trading

James Rolke Net Worth

The estimated net worth of James Rolke is at least $474,773 dollars as of 2024-05-05. James Rolke is the Chief Scientific Officer of La Jolla Pharmaceutical Co and owns about 76,330 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $474,773. Details can be seen in James Rolke's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Rolke has not made any transactions after 2019-01-09 and currently still holds the listed stock(s).

Transaction Summary of James Rolke

To

James Rolke Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Rolke owns 2 companies in total, including La Jolla Pharmaceutical Co (LJPC) , and Revelation Biosciences Inc (REVB) .

Click here to see the complete history of James Rolke’s form 4 insider trades.

Insider Ownership Summary of James Rolke

Ticker Comapny Transaction Date Type of Owner
LJPC La Jolla Pharmaceutical Co 2019-01-09 Chief Scientific Officer
REVB Revelation Biosciences Inc 2022-01-10 director & Chief Executive Officer

James Rolke Latest Holdings Summary

James Rolke currently owns a total of 1 stock. James Rolke owns 76,330 shares of La Jolla Pharmaceutical Co (LJPC) as of January 9, 2019, with a value of $474,773.

Latest Holdings of James Rolke

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LJPC La Jolla Pharmaceutical Co 2019-01-09 76,330 6.22 474,773

Holding Weightings of James Rolke


James Rolke Form 4 Trading Tracker

According to the SEC Form 4 filings, James Rolke has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 1,600 shares on January 9, 2019, which cost James Rolke around $9,744.

Insider Trading History of James Rolke

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Rolke Trading Performance

GuruFocus tracks the stock performance after each of James Rolke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Rolke is -7.37%. GuruFocus also compares James Rolke's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Rolke within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Rolke's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Rolke

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.49
Relative Return to S&P 500(%) -11

James Rolke Ownership Network

Ownership Network List of James Rolke

No Data

Ownership Network Relation of James Rolke


James Rolke Owned Company Details

What does La Jolla Pharmaceutical Co do?

Who are the key executives at La Jolla Pharmaceutical Co?

James Rolke is the Chief Scientific Officer of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , director & Chief Executive Officer Larry G. Edwards , and Chief Financial Officer Michael S Hearne .

La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

La Jolla Pharmaceutical Co Insider Transactions

No Available Data

James Rolke Mailing Address

Above is the net worth, insider trading, and ownership report for James Rolke. You might contact James Rolke via mailing address: 10182 Telesis Court, 6th Floor, San Diego Ca 92121.

Discussions on James Rolke

No discussions yet.